Actinomycetes have provided two-thirds of the known bioactive compounds that dramatically improved human health in the latter half of the 20th century. However, with increasing drug resistance of pathogenic organisms, new sources of antibiotics with molecular diversity are increasingly in demand. Myxobacteria are relatively large, rod-shaped gram-negative bacteria characterized by a gliding and gathering nature as they form multi-cellular fruiting bodies. They have recently been recognized as outstanding producers of novel bioactive secondary metabolites despite their low productivity. 1, 2) Most of these secondary metabolites are biosynthesized by multifunctional megaenzymes known as polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), which are generally called modules. Each module is responsible for one complete cycle of ketide or peptide chain elongation including functional group modification. One module can be divided into different domains where each domain catalyzes one specific biochemical reaction. Recent knowledge regarding the PKS/NRPS genes has made it possible to biosynthesize novel complex bioactive products using molecular genetic methodology. [3] [4] [5] Myxobacteria have thus been recognized as novel resources from the viewpoint not only of metabolomics but also of genomics, although there are considerably fewer genetic and biochemical studies of myxobacteria than of actinomycetes. 2) We have isolated two classes of antifungal secondary metabolites, consisting of more than ten derivatives, from the myxobacterium Cystobacter fuscus strain AJ-13278, [6] [7] [8] [9] among which cystothiazole A (Fig. 1) is the most potent agent. We have also reported biosynthetic studies on cystothiazole A through feeding experiments to identify its biosynthetic precursors and to suggest that this antibiotic is biosynthesized by a hybrid PKS/NRPS multienzyme system. 10) In this report, we describe the cloning, sequencing, and characterization of the hybrid PKS/NRPS gene cluster for cystothiazole A biosynthesis in C. fuscus strain AJ-13278 and propose a model of the biosynthetic pathway. This is the first report of an antibiotic biosynthetic system from the myxobacterial genus Cystobacter.
Materials and Methods
Bacterial strains and culture conditions. The strains used in this study are listed in Table 1 . Escherichia coli strains were cultured in Luria-Bertani (LB) medium at y To whom correspondence should be addressed. Fax: +81-52-789-4284; E-mail: ojika@agr.nagoya-u.ac.jp Abbreviations: A, adenylation domain; ACP, acyl carrier protein; AT, acyl transferase; BAC, bacterial artificial chromosome; C, condensation domain; DH, -hydroxylacyl-ACP dehydratase; HC, heterocyclization domain; HPLC, high-performance liquid chromatography; KR, -ketoacyl reductase; KS, -ketoacyl synthase; MOX, monooxygenase; NRPS, nonribosomal peptide synthetase; Ox, oxidation domain; O-MT, O-methyl transferase; PCP, peptidyl carrier protein; PFGE, pulsed-field gel electrophoresis; PKS, polyketide synthase; S, spacer region; TE, thioesterase C. Casitone medium (2% Difco Casitone, 0.1% 2% SEPABEADS SP207 resin (Mitsubishi Chemical, Tokyo)) was used for cystothiazole A production by C. fuscus at 30 C. Antibiotics were added, when necessary, at the following final concentrations: 50 mg/ ml kanamycin sulphate, 12.5 mg/ml chloramphenicol, 50 mg/ml ampicillin.
DNA manipulations, sequencing, and PCR. Chromosomal DNAs of C. fuscus strains for PCR were prepared using a previously described protocol.
11) Degenerated primers KSU (CTXGCXATGGAYCCXCARCARMG) and KSD (TGTGTXCCXGTXCCRTGXGCYTC) were used for amplification of -ketoacyl synthase (KS) domain fragments from C. fuscus. An approximately 700-bp fragment, KS1, was obtained by PCR with a GeneAmp PCR System 9700 (Applied Biosystems) using EX Taq DNA polymerase (Takara) and the following cycling conditions: (1) 1 min at 94 C, 1 min at 55 C, 1 min at 72 C for 5 cycles; (2) 1 min at 94 C, 1 min at 45 C, 1 min at 72 C for 5 cycles; (3) 1 min at 94 C, 1 min at 38 C, 1 min at 72 C for 25 cycles. Other detailed conditions for the PCR reaction were set according to the user's manual. The PCR product was ligated into pCR 2.1-TOPO vector using the TOPO TA Cloning kit (Invitrogen). After transformation, eight clones were randomly picked and the plasmids were sequenced on an ABI PRISMÔ 310 Genetic Analyzer (Applied Biosystems). The sequences of these clones were completely identical, and one of them, pKS1, was used for the mutation experiments. A DNA fragment within an ORF of unknown function (orf5) was obtained using the GeneAmp PCR System 9700 with EX Taq DNA polymerase, primers CYSOU (GGAAGAT-CATGGCCCATTCCCTCC) and CYSOD (ATCCGC-TACGACCATCGGGACACC), and BAC clone p3-1B as a template. The PCR product was ligated into pCR 2.1-TOPO vector using the TOPO TA Cloning kit to produce plasmid pORF5 in a manner similar to that for pKS1. All other DNA manipulations were performed according to the standard protocols.
12)
Preparation of genomic walking library. A genomic walking library was constructed with the Universal Preparation and screening of the bacterial artificial chromosome (BAC) library. C. fuscus was cultured to an OD 620 of 0.8-0.9 in Casitone medium at 30 C with shaking at 160 rpm for about 2 d. Chromosomal DNA was extracted from the C. fuscus cells in CertifiedÔ Low Melt Agarose (Bio-Rad), as previously described.
13) The DNA in each agarose plug was partially digested with 8 units of BamHI in 40 ml of digestion buffer for 20 min at 37 C following an online protocol. 14) Size fractionation and purification of the partially digested DNA were also performed following this protocol, with a slight modification. The partially digested DNA in the agarose plugs was fractionated on 1% CertifiedÔ Low Melt Agarose (Bio-Rad) gel by pulsed-field gel electrophoresis (PFGE) using a CHEF-DR II apparatus (Bio-Rad) at 200 V with a pulse time of 1 to 40 s for 18 h. A piece of agarose containing DNA fragments about 100 kb in size was excised from the gel and used for the second PFGE at 200 V with a pulse time of 3 to 5 s for 12 h. A piece of agarose containing DNA fragments about 100 kb in size was again excised. The excised gel (250 mg) was melted at 65 C for 10 min and digested with 3.75 units of GELaseÔ (Epicentre) at 45 C for 1.5 h, and the DNA solution was used directly for ligation.
A CopyControlÔ BAC Cloning Kit containing pCC1BACÔ (BamHI) and EPI300Ô Electrocompetent E. coli (Epicentre) were used to construct the BAC library of C. fuscus genomic DNA according to the manufacture's instructions. After checking the average insertion size (80 kb) of 20 BAC clones by BamHI digestion followed by agarose gel electrophoresis, the E. coli transformants were cultured on eight 96-well microplates overnight. The library plates were stored at À80 C after glycerol was added to a final concentration of 15%.
The cystothiazole A biosynthetic gene cluster was first screened by colony hybridization using the right terminal fragment R11 obtained from the genomic walking library (Fig. 3A) as a probe. The Gene Images AlkPhos Direct Labelling and Detection System (Amersham Biosciences) was used for probe labeling and signal detection. Eighteen positive clones were obtained and these were screened again by PCR with primers L11U (CTGGGGGAGGCTGATGGTGTAGTGCGT) and L11D (CTCCTCGCGGTTGCGAGGTGGGTT-GCT) derived from the left terminal fragment L11 (Fig. 3A) . Two BAC clones, p1-11F and p3-1B, were finally obtained. After sequencing their insertion termini, clone p3-1B, which had no homology to PKS or NRPS genes at the insertion termini, was chosen and subjected to shotgun sequencing (Takara, Otsu). Briefly, DNA sequences were determined for 480 subclones with an average length of 2.5 kb insertion in the pUC118 vector. Sequence reactions were carried out using the M13-47 and RV-M primers and a DYEnamic ET Dye Terminator kit (Amersham Biosciences) on a Mega-BACE4000 sequencer (Amersham Biosciences). Gaps were covered by primer walking. The sequence data were assembled with PGA (Paracel Genome Assembler, Paracel, Pasadena, U.S.A.).
Construction of C. fuscus mutant strains. C. fuscus cells, obtained from 100 ml Casitone medium as described above, were washed twice with 50 ml of 10% glycerol, resuspended in 1 ml 10% glycerol, and then split into 10 aliquots. Plasmids pKS1 and pORF5 obtained from E. coli TOPO 10 were transformed into the new host E. coli ET12567 to obtain plasmids of the unmethylated form.
15) The plasmids obtained from E. coli ET12567 were denatured according to the previously reported procedure, 16) and then dissolved in an aliquot of the C. fuscus cell suspension. Electroporation was performed at room temperature (2 kV, 200 , 25 mF in 2 mm cuvettes) on a Bio-Rad Gene Pulser. The electroporated cells were resuspended in 50 ml of Casitone medium and cultured with shaking at 160 rpm for 18 h at 30 C. The cells were collected by centrifugation, plated on Cy plates containing 50 mg/ml kanamycin, and then cultured at 30 C for about 1 week. The desired insertion of the plasmid in the transformants was confirmed by PCR with primers C1 (TCTCGTT-CTTCTCGGAGCAGGAGGCAC) and C6 (GCGTGA-GGTTGAAGTAGGGGTTGGGCT), the designs of which were based on the gene cluster sequence, as well as primers C2 (GGATGTGCTGCAAGGCGATTAAG-TTGG), C3 (TCGGCTATGACTGGGCACAACAG-AC), C4 (GGCGATACCGTAAAGCACGAGGAAG), and C5 (GGCTTTACACTTTATGCTTCCGGCTCG), the designs of which were based on the plasmid pKS1 sequence ( Fig. 2A) .
High-performance liquid chromatography (HPLC) analysis of secondary metabolite production in C. fuscus. For production of secondary metabolites, the strains were cultured in 5 ml of the production medium for 3 d at 30
C with shaking at 160 rpm. The resin and cells were collected by centrifugation, resuspended in 1 ml of acetone, sonicated for 3 min, and then shaken at 100 rpm for 2 h at room temperature. The supernatant was collected and dried under an N 2 stream. The extract was dissolved in 50 ml of methanol, and a portion (3 ml) was subjected to HPLC analysis under the following conditions: column, Develosil ODS-HG-5 (4:6 Â 250 mm); solvent, 60% to 90% acetonitrile in water in 30 min; flow rate, 1 ml/min; detection range, 200-400 nm.
Sequence analysis and nucleotide sequence accession number. The DNA and deduced protein sequences were analyzed though the GenBank database by BLAST search. The sequence of the cystothiazole A biosynthetic gene cluster reported here has been deposited in the GenBank database under accession no. AY834753.
Results and Discussion
Identification of a KS domain fragment within the cystothiazole A biosynthetic gene cluster (cta gene cluster)
Using primers based on the conserved amino acid sequences of KS domains from type I PKSs, 17) the target DNA fragments were amplified from the chromosomal DNA of C. fuscus AJ-13278. Sequence analysis showed that the PCR fragments in the eight plasmids had identical sequences, which were homologous to PKS genes. One of the plasmids carrying the PCR product, pKS1, was introduced into C. fuscus by electroporation to carry out gene disruption via homologous recombi- 4) with primers C1-C2 and C5-C6, respectively. D, HPLC analysis of the extracts from C. fuscus wild-type and MKS1 mutant strain. The asterisks indicate cystothiazole A derivatives, [6] [7] [8] and the dots indicate myxalamide derivatives. 9) nation ( Fig. 2A) . Integration of pKS1 in a kanamycinresistant transformant, MKS1, was verified by PCR with three pairs of primers designed on both the plasmid pKS1 and the gene cluster sequences (Fig. 2B, C) . The production not only of cystothiazole A, but also of its derivatives, was completely arrested in MKS1 (Fig. 2D) , indicating that the KS1 fragment was located within the cystothiazole A biosynthetic gene cluster.
Construction and screening of a BAC library for the cta gene cluster
Prior to the construction of a BAC library for the C. fuscus genome, genomic walking was performed to obtain information on the terminal sequences and the approximate size of the cystothiazole A biosynthetic gene cluster. Gene walking was started with the KS1 fragment and finally encompassed the 35-kb range of the gene cluster by 23 clones, forming a continuous sequence (Fig. 3A) .
A genomic library of C. fuscus AJ-13278 was constructed using a BAC vector. Approximately 800 chloramphenicol-resistant BAC clones were obtained with an average insertion size of 80 kb. Of these, 18 positive clones were identified by colony hybridization using the right-terminal fragment (R11), which was identified by the gene walking experiments (Fig. 3A) , as a probe. Finally, two clones, p1-11F and p3-1B, were identified using the primers based on the sequence of the left-terminal fragment (L11) of the genomic walking library (Fig. 3A) . The DNA sequences of the insertion termini of the clones were not homologous to the PKS/ NRPS genes in p3-1B, whereas the terminal sequence of p1-11F showed an NRPS homology, suggesting that the insert of BAC plasmid p3-1B entirely covered the gene cluster.
In studies on natural product biosynthetic gene clusters, cosmid libraries have been widely used, but it is difficult to obtain the complete gene cluster in a single cosmid clone because of the large size of the gene clusters and the limited insertion size of cosmid vectors. In this study, we constructed a genomic BAC library of the antibiotic producing myxobacterium C. fuscus and successfully cloned the complete antibiotic biosynthetic gene cluster cta in one BAC plasmid.
Analysis of the cta genes
Shotgun DNA sequencing of BAC clone p3-1B, which contained a 73.6-kb insert, produced a 63.9-kb contiguous DNA sequence containing 17 ORFs and encompassing the cystothiazole A biosynthetic gene cluster (Fig. 3C) . The sequence showed a typical myxobacterial GC content of 70.3%. Results of the comparisons of the deduced amino acid sequences of each ORF with the protein database are shown in Tables 2 and 3 .
The cta gene cluster showed high homology to the mta gene cluster from Stigmatella aurantiaca 18) and the mel gene cluster from Melittangium lichenicola 19) ( Fig. 4) , which are responsible for myxothiazol and melithiazol ( Fig. 1) biosynthesis, respectively. Hence, we named our cta genes following the naming systems in the mta and mel gene clusters: ctaB to ctaG in the PKS/NRPS gene cluster, and ctaJ and ctaK downstream of the gene cluster. Genes ctaB, ctaE, and ctaF and the 3 0 -half of ctaD are quite similar to type I PKS genes, and the encoded proteins are likely involved in the formation of the polyketide carbon chain. On the other hand, genes ctaC and ctaG and the 5 0 -half of ctaD show similarity to NRPS genes, and the encoded proteins are likely involved in the formation of the peptide (cysteinyl cysteine) followed by cyclization into the two thiazole rings. Based on the arrangement of the functional domains and the genes, as well as the chemical structure, the cta gene cluster appears to initiate at a PKS gene (ctaB) followed by NRPS genes (ctaC, the 5 0 -half of ctaD) and PKS genes (the 3 0 -half of ctaD, ctaE, ctaF), and finally to end at an NRPS gene (ctaG) (Fig. 3C) .
A proposed model of cystothiazole A biosynthesis is shown in Fig. 4 . CtaB consists of one module that contains one KS domain, one acyltransferase (AT) domain, and one acyl carrier protein (ACP) domain. In this module, an isobutyryl group, which is derived from L-valine via amino acid degradation as previously demonstrated, 10) is the probable starter unit. There is an NRPS module in both CtaC and CtaD (N-terminus) following CtaB. The adenylation (A) domain in these two modules might recognize cysteine as the substrate, and the oxidation (Ox) domain is likely to catalyze the formation of the bithiazole structure of cystothiazole A, which is then transferred to the next PKS module CtaD (C-terminus). This module comprises the auxiliary domains, -hydroxylacyl-ACP dehydratase (DH) and -ketoacyl reductase (KR), which must catalyze the formation of the double bond (C6-C7 in Fig. 1 ). CtaD is a hybrid NRPS/PKS multienzyme protein that has been found only in a few myxobacteria, 18, 19) and it is a good candidate for study of the biosynthesis of hybrid NRPS/ PKS type antibiotics. Genes ctaE and ctaF, downstream of ctaD, both encode PKSs, CtaE and CtaF, which contain auxiliary domains homologous to SAM-dependent methyltransferases (MT). This kind of MT domain is similar to that of O-methyltransferases (O-MT), and has been reported only in the myxobacteria Stigmatella aurantiaca 18) and Melittangium lichenicola. 19) By comparing the chemical structure of cystothiazole A with the arrangement of the cta gene cluster, it can be deduced that the MT domain in CtaE and CtaF catalyzes O-methylation at positions C-5 and C-3, respectively, during cystothiazole A biosynthesis. The NRPS gene, ctaG, was found at the terminus of the cta gene cluster. The domains in CtaG are arranged as condensation (C)-adenylation (A)-monooxygenase (MOX)-peptidyl carrier protein (PCP)-thioesterase (TE), in which the C, A, and PCP domains are necessary for one peptide chain elongation cycle and the TE domain is needed for release of the product. MOX is a special domain inserted into the A domain, a configuration also found in the mta and mel gene clusters, 18, 19) suggesting that an extra Cystothiazole A biosynthesis starts at a PKS (CtaB), followed by two NRPSs, and then by three PKSs, and ends at an NRPS (CtaG). The TE domain in CtaG catalyzes the release of the cystothiazole A chain, and the biosynthesis is completed by CtaJ and CtaK. The A domain in CtaD consists of A 1{8 and A 9{10 , and the A domain in CtaG consists of A 1{4 and A 5{10 , because of the insertion of Ox and MOX, respectively, into A. amino acid (glycine) activated by the A domain of CtaG is transferred to the ACP-bound cystothiazole acyl chain on the upstream PKS (CtaF), then the carbon backbone of this amino acid is removed by the MOX domain, resulting in the terminal amide structure (Fig. 4) .
Examination of involvement of orf5 in cystothiazole A biosynthesis
An ORF encoding a protein homologous to hydrolases and acetyltransferases (orf5) is located approximately 680 bp upstream of the ctaB gene. In order to clarify the function of orf5 in cystothiazole A biosynthesis, an internal fragment of orf5 was amplified by PCR with primers CYSOU and CYSOD and cloned into pCR 2.1-TOPO vector. The resulting plasmid, pORF5, was used for disruption of orf5, and integration of pORF5 at the desired locus was verified via PCR. The disruptant MCYO5 was still able to produce cystothiazole A (data not shown), suggesting that ORF5 is not involved in cystothiazole A biosynthesis and that the cta gene cluster starts from the ctaB gene.
Analysis of ctaJ and ctaK genes
Two genes, ctaJ and ctaK, downstream of the PKS/ NRPS gene cluster show homology to melJ and melK, respectively, which are involved in the melithiazol biosynthesis in M. lichenicola. 19) CtaJ and CtaK appear to be responsible for the formation of the methyl ester of cystothiazole A. CtaJ is homologous to the nitrilase superfamily. The enzymes in this superfamily catalyze reactions through a thiol acylenzyme intermediate, and the activity depends on the novel Glu-Lys-Cys catalytic triad. 20) This catalytic triad can be found at position Glu52-Lys120-Cys153 in CtaJ. Therefore, CtaJ should be responsible for a hydrolysis reaction, as described below. In contrast, CtaK shows homology to Omethyltransferases (O-MT) involved in polyketide biosynthesis. Therefore, after the amide is released from CtaG by the TE domain and hydrolyzed by CtaJ, CtaK might methylate the resulting carboxylate. Alternatively, CtaK catalyzes methyl transfer to produce an imidate, which is hydrolyzed by CtaJ to cystothiazole A, as suggested in a report on the mel gene cluster. 19) Comparison of the cta, mel, and mta genes Our results indicate that the cta gene cluster involved in cystothiazole A biosynthesis has a modular organization similar to that of the mta and mel gene clusters from S. aurantiaca and M. lichenicola, respectively (Fig. 4) . 18, 19) It is interesting to compare the three related gene clusters cta, mel, and mta from an evolutionary viewpoint. The modular organizations in cta, mel, and mta are consistent with the chemical structures of their products and are similar to each other. However, there are several notable differences among these gene clusters. Upstream of the mta gene cluster, there is a gene (mtaA) encoding a 4 0 -phosphopantetheinyl transferase, which activates the biosynthesis of myxothiazol, whereas no homologous gene was found upstream of either the mel or the cta gene cluster. On the other hand, orf2, which is homologous to L-amino acid oxidase genes, is located upstream of the mel gene cluster, and ORF2 is expected to catalyze the dehydrogenation of the methyl group (C-15) to methylene in melithiazol biosynthesis, but no homologous genes were found upstream of either the cta or the mta gene cluster. Downstream of the cta and mel gene clusters, the carbon-nitrogen hydrolase (ctaJ and melJ) and Omethyltransferase genes (ctaK and melK) were identified as modifying enzymes for the final construction of the antibiotics, whereas no homologous gene has been found downstream of the mta gene cluster. As for the starter PKS modules in these gene clusters, the domain organization of mtaB shows a large difference from both ctaB and melB, which is reflected in the alkyl substituent structure of the bithiazole moiety of these antibiotics. Since it has been suggested that the melH and mtaH genes downstream of the mel and mta gene clusters, respectively, are not involved in antibiotics biosynthesis, 19) the homologous gene orf6 we identified downstream of the cta gene cluster also appears not to be involved in cystothiazole A biosynthesis. Such similarities and differences among the cta, mel, and mta gene clusters suggest that these gene clusters are derived from a common ancestor. 21) This is supported by the fact that the cystothiazole A producer (Cystobacter sp.), myxothiazol producers (Myxococcus sp. and Stigmatella sp.), and melithiazol producer (Mellitangium sp.) are closely related phylogenetically. 22) 
